# Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

> **NCT00378755** · PHASE2 · UNKNOWN · sponsor: **Korean Multiple Myeloma Working Party** · enrollment: 62 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** velcade

## Key facts

- **NCT ID:** NCT00378755
- **Lead sponsor:** Korean Multiple Myeloma Working Party
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 62 (—)
- **Last updated:** 2006-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378755, "Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00378755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*